Senior insider sale
Chief Accounting Officer at CORCEPT THERAPEUTICS INC — senior position signals high conviction
$2.46M
21.54K shares
What this filing means
LYON JOSEPH DOUGLAS plans to sell 21.54K shares of CORCEPT THERAPEUTICS INC valued at approximately $2.46M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/1/2026ACC: 0001973251-26-000038
Officer· Chief Accounting Officer
Since Jul 2020
21.54K
Shares to sell
$2.46M
Approx. market value
10K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
stock option exercise
cash
10/1/2026
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/1/2026 | stock option exercise cash | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
10K
Market value
$1.13M
9/14/2026
—Completed
Units to sell
1.54K
Market value
$175.7K
8/3/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
10K
Market value
$1.15M
10/1/2026
Total
Units
21.54K
Value
$2.46M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/14/2026 | 10K | $1.13M | — | Completed |
8/3/2026 | 1.54K | $175.7K | — | Completed |
| Planned — Approximate Date | ||||
10/1/2026 | 10K | $1.15M | NASDAQ | Planned |
| Total | 21.54K | $2.46M | ||